Today in NPC This Week: What will PBM reform look like, 340B in the states, the IRA’s impact on postapproval research, NPC’s 2025 board leadership, and more ☃️ NPC This Week will pause over the holidays. Look for us again in your inbox on Tuesday, January 7, 2025. Happy holidays from the NPC team! Want to get NPC This Week in your inbox? Subscribe here: https://lnkd.in/ekY9Dxzr
National Pharmaceutical Council’s Post
More Relevant Posts
-
Are you prepared for unexpected leadership transitions? Most organizations aren’t. In this PharmExec.com featured article, learn how strategic succession planning can fortify your organization's stability, growth, and future: https://bit.ly/3XAtYz7 #StrategyMadePersonal #SuccessionPlanning #LeadershipTransition #LeadershipDevelopment #ExecutiveLeadership #LeadershipSuccession
Pharmaceutical Executive
pharmexec.com
-
#PDA: #Pharmacy professional leadership board must publish more details about members. The #Pharmacists’ Defence Association has urged the UK Pharmacy Professional Leadership Advisory Board (#UKPPLAB) to be “open and transparent with pharmacists” about any organisations its members are associated and involved with as they prepare to meet for the first time tomorrow. Want to find out more? Visit the #PharmacyMagazine website to check out the full #article if you are interested:
PDA: Pharmacy professional leadership board must publish more details about members
pharmacymagazine.co.uk
-
Our work as healthcare leaders is personal. From the patients and families who inspire our pipeline and critical work, to the colleagues and teams who help drive innovation forward, authentic leadership can have a lasting impact. As leaders, prioritizing compassion and leading with empathy allows us to better serve others and keep patients as the priority. I sat down with Authority Magazine to discuss the impact empathy can have on leadership. Read the full interview here: https://bit.ly/4fuFYbV and tell me, what does empathetic leadership look like to you? #BMS_employee #HealthcareInnovation #Leadership #Empathy
Bristol Myers Squibb’s Wendy Short Bartie: 5 Ways Empathy Will Affect Your Leadership
medium.com
-
STEM education strategist, NEP 2020 policy maker, Higher Education Transformation Evangelist, Public Speaker
leadership, vision, pace, transparency, innovation, what else, everything needed for the company's transformation is practiced with evident results... #innovation #leadership
A Decade Of Innovation: How This CEO Transformed A Global Pharma Giant
forbes.com
-
Senior Associate - Healthcare and Social Impact & Non-Profit Executive Search
We are thrilled to announce the release of our most recent report by Morten Nielsen and Mindy Steiger, which delves into the role of Contract Development and Manufacturing Organizations (CDMOs) within the pharmaceutical industry. This comprehensive analysis highlights key industry trends and offers insightful glimpses into the leadership teams and boardrooms of leading CDMOs. CDMOs have become indispensable pillars of the pharmaceutical value chain, standing out as trusted business partners dedicated to meeting the burgeoning demand for innovative medicines and adaptive solutions. Over the past three decades, this industry has undergone a remarkable transformation, necessitating a recalibration of leadership requirements. To thrive, we recommend that CDMOs consider augmenting their leadership teams with competencies in: 💡 Digital Transformation 💡 Artificial Intelligence 💡 ESG/Sustainability 💡 Cutting-edge Modalities (including cell, gene, and mRNA therapies) Prominent players in the Quality of Life Ecosystem, CDMOs are uniquely positioned to drive progress in addressing global healthcare challenges and improving patient outcomes. Please review our detailed talent insights and leadership recommendations to learn more. ⬇ #CDMO #ImpactfulLeadership
New Report | Navigating the Evolving Landscape in CDMO Leadership
wkwisdom.com
-
We are starting this fruitfull week by discussing this topic ( market acces) while we are preparing curiculum for a FMCG company and similiar. This article is helping me and my partner mr Wawan Rahardianto, MBA to have the inspiring idea to elaborate classic leadership (i.e John C Maxwell, Ken Blanchard) to Agile Leadership Happy reading, hghly approeciate to the writer
What is Market Access? ©
Andrea Mantovani 🌍 on LinkedIn
-
Effective #ChangeLeadership starts with understanding your team's culture. Dive into our latest case study "Building a Culture of Collaboration" to learn more. https://lnkd.in/eWrr9a4h 🔍🌟 #Leadership #StrategicChange
Building a Culture of Collaboration for an Oncology Business Unit
wlhconsulting.com
-
We are thrilled to announce the release of our most recent report by Morten Nielsen and Mindy Steiger, which delves into the role of Contract Development and Manufacturing Organizations (CDMOs) within the pharmaceutical industry. This comprehensive analysis highlights key industry trends and offers insightful glimpses into the leadership teams and boardrooms of leading CDMOs. CDMOs have become indispensable pillars of the pharmaceutical value chain, standing out as trusted business partners dedicated to meeting the burgeoning demand for innovative medicines and adaptive solutions. Over the past three decades, this industry has undergone a remarkable transformation, necessitating a recalibration of leadership requirements. To thrive, we recommend that CDMOs consider augmenting their leadership teams with competencies in: 💡 Digital Transformation 💡 Artificial Intelligence 💡 ESG/Sustainability 💡 Cutting-edge Modalities (including cell, gene, and mRNA therapies) Prominent players in the Quality of Life Ecosystem, CDMOs are uniquely positioned to drive progress in addressing global healthcare challenges and improving patient outcomes. Please review our detailed talent insights and leadership recommendations to learn more. ⬇ #CDMO #ImpactfulLeadership
Adapting to Change: The Shifting CDMO Leadership Landscape
wkwisdom.com
-
Global Healthcare & Industrials Equity Research Analyst | Medical Doctor | Equity Portfolio Manager | Climate Risk Professional | Entrepreneur | Speaker | Chartered Banker | Mentor | Coach | NED | Chartered AI Analyst
Leadership is More Than Just Results: It's About Inspiring Dreams. Great leaders don't just chase numbers - they ignite #passion! I came across this powerful quote from Pascal Soriot, the visionary CEO of AstraZeneca: "The value of making people dream, setting a big goal, and then stretching and trying to achieve it." This perfectly captures the essence of leadership. It's about inspiring your team, setting a #vision that excites them, and then working together to push boundaries and make it a reality. What are your thoughts on this leadership philosophy? #Leadership #innovation #purpose #oncology #obesity #personalizedmedicine https://lnkd.in/egRsseGz
AstraZeneca’s CEO Isn’t Distracted by the Race to Tackle Obesity
bloomberg.com
-
We are thrilled to announce the release of our most recent report by Morten Nielsen and Mindy Steiger, which delves into the role of Contract Development and Manufacturing Organizations (CDMOs) within the pharmaceutical industry. This comprehensive analysis highlights key industry trends and offers insightful glimpses into the leadership teams and boardrooms of leading CDMOs. CDMOs have become indispensable pillars of the pharmaceutical value chain, standing out as trusted business partners dedicated to meeting the burgeoning demand for innovative medicines and adaptive solutions. Over the past three decades, this industry has undergone a remarkable transformation, necessitating a recalibration of leadership requirements. To thrive, we recommend that CDMOs consider augmenting their leadership teams with competencies in: 💡 Digital Transformation 💡 Artificial Intelligence 💡 ESG/Sustainability 💡 Cutting-edge Modalities (including cell, gene, and mRNA therapies) Prominent players in the Quality of Life Ecosystem, CDMOs are uniquely positioned to drive progress in addressing global healthcare challenges and improving patient outcomes. Please review our detailed talent insights and leadership recommendations to learn more. ⬇ #CDMO #ImpactfulLeadership
New Report | Navigating the Evolving Landscape in CDMO Leadership
wkwisdom.com
More from this author
-
In this issue: What will PBM reform look like, 340B in the states, the IRA’s impact on postapproval research, NPC’s 2025 board leadership, and more.
-
In this issue: 340B reform, FDA accelerated approvals, and more.
-
In this issue: Measures to increase gene therapy access, new state 340B data, proposed CMS changes, and more.
VP & US Head, Public Affairs & Patient Advocacy | Patient Engagement | Policy | Equitable Access | Artificial Intelligence
4dCongratulations to the newly appointed NPC Board of Directors members! Thank you so much National Pharmaceutical Council Michael Pratt John O'Brien for sharing the latest episode of the Patient Advocacy Voices podcast featuring Randall Rutta from the National Health Council with your audience. NHC plays a critical role in ensuring the voice of patients is heard.